Symposium: New Drugs on the Horizon

18/06/2025 09:20 10:55

Auditorium I

WestermarckJukka Co-Chair Finland

CaffarelMaria M. Co-Chair Spain

Time	Session

09:20 09:45	Drugging transcription factors: HSF1 and Brachyury WorkmanPaul Speaker United Kingdom
09:45 09:55	Proffered Paper: Inhibition of WEE1 kinase activity to overcome secondary resistance to targeted therapies in colorectal cancer EACR25-0376 EACR25-0376 ArenaSabrina Presenter Italy
09:55 10:20	Targeting chromatin proteins for therapeutic benefit in haematological malignancy SomervailleTim Speaker United Kingdom
10:20 10:30	Proffered Paper: Reversing Acidic Immune Suppression in Cancer with PTT-4256, A First-In-Class Small Molecule Inhibitor of GPR65 EACR25-0553 EACR25-0553 CorbinAlastair Presenter United Kingdom
10:30 10:55	PP2A inhibitor protein CIP2A is a prime target for TNBC therapy WestermarckJukka Speaker Finland